Axon stock forecast shows bullish momentum into Q2 2024, with market analysts projecting a potential price range of $280–$295, supported by rising demand in law enforcement tech and consistent revenue growth above 25% YoY. Analyst reasoning : "We believe BRZE's shares are attractive at 4x CY26 revenue, trading at a discount to SMID apps peers at 11x despite superior growth prospects (20%+ vs. peers in high-teens). Sustained 20%+ revenue growth is supported by customer and partner field checks showing teens-plus spend growth." Connected Devices revenue rose 29% year over year to $376 million , reflecting strength across all major device lines. TASER revenue grew 19% to $216 million , driven by demand for TASER 10. Personal Sensors revenue increased 24% to $93 million , supported by adoption of Axon Body 4. Platform Solutions revenue grew 86% to $67 million , showcasing strong market demand for emerging products, including counter-drone and VR training. Following strong Q1 results, the Axon stock forecast now reflects an upward revision in target price, with analysts citing steady gross margin improvements.